Pharmaceutical stocks saw strong buying interest, pushing the Nifty Pharma to a new 52-week high of 24,033 during Wednesday’s trading session.
The index has risen for 5 straight sessions and gained 3.8% during this period, clearly outperforming the Nifty 50, which rose only 0.37%.
Wockhardt Leads The Surge
Among individual stocks, Wockhardt jumped around 15% amid heavy trading volumes. The stock has surged about 23% in just 2 trading sessions.
Other pharma companies also gained:
- Ajanta Pharma rose about 7%
- Biocon, Alkem Laboratories, Piramal Pharma, Aurobindo Pharma and Lupin gained around 4%
- Zydus Life Sciences, Laurus Labs, Cipla, Dr. Reddy's Laboratories and JB Chemicals & Pharmaceuticals rose 2–3%.
Stocks like Lupin, Laurus Labs, Granules India and Sai Life Sciences touched new highs. Sun Pharma, Aurobindo Pharma and Natco Pharma also hit 52-week highs.
Strong Earnings Driving The Rally
The pharma sector has been rising mainly due to strong quarterly results.
Wockhardt reported:
- 30% year-on-year revenue growth
- 147% jump in EBITDA to ₹196 crore
Its biotech business grew 126% year-on-year, supported by growth in emerging markets such as Thailand, Egypt and Algeria. The company expects future growth from upcoming insulin analog launches.
Read more: Aditya Birla Real Estate FY26 Results: Higher Dividend as Realty Shift Gains Pace.
Positive Outlook For Ajanta Pharma
Ajanta Pharma’s growth was supported by:
- New product launches in India
- Strong performance in the US market
- Market share gains in existing products
Conclusion
The pharma sector continues to outperform the broader market, supported by strong earnings, new product launches and positive long-term growth prospects. Continued innovation and global expansion could keep the sector in focus.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
